Dan Knightly
195.5K posts

Dan Knightly retweetledi

@RobSchneider Wait times for pedophiles in government being arrested in the US....
English


@PierrePoilievre really appreciate you not backing down on Rogan when it came to Trump and his 51st state remarks. "I wish he'd cut that shit out" 👍
English

LOOK IT UP, YOURSELVES YOU DUMB CANADIAN RETARDS!!
IT IS TRUE!! YOUR INSANE CANADIAN COUNTRY OFFERS SAME DAY SUICIDES!!! @Grok confirms 👇🇺🇸🇺🇸

English

@nastyflyergirl Its weird he was traded twice. But I dont think it has to do with him
English

@DanKnightly I’m hoping he just needed a change of scenery with an organization who will have more patience. Obviously Minnesota is in a win now
English
Dan Knightly retweetledi

You were born with cells whose only job is to find and kill cancer. They're called natural killer cells. In most cancer patients, they don't show up in large enough numbers or stay active long enough to win. A drug called Anktiva changes that, and the early results are wild.
Anktiva works by flipping a protein switch in your body that tells your natural killer cells to multiply faster and fight harder. Chemo poisons cancer but destroys your immune system along the way, which is why patients lose their hair, get infections, and feel wrecked. Anktiva does the opposite. Instead of poisoning everything and hoping cancer dies first, it powers up the defense system you were already born with.
The FDA approved it in April 2024 for one specific type of bladder cancer. It was tested on 77 patients. In 6 out of 10 cases, all detectable signs of cancer disappeared completely. 40% of those patients stayed cancer-free for two years or more. But the number that stands out: six patients from that original group were checked 9 years later. All six are still cancer-free. From a drug that has never been used in chemotherapy.
In January 2026, Saudi Arabia became the first country to approve Anktiva for lung cancer, not just bladder cancer. It's now approved in 33 countries. Sales hit $113 million last year, up 700% from the year before. The EU approved it in February 2026. Trials are running in pancreatic cancer, brain cancer, and a handful of others.
The catch: the U.S. FDA has been pushing back hard. It refused to expand Anktiva's approval to additional patients with bladder cancer in May 2025. It caught the company exaggerating results on its website twice. The company paid $10.5 million to settle a lawsuit filed by investors who said leadership overpromised about how ready their factories were. The gap between 77 patients with bladder cancer and a broad cancer treatment is still enormous.
(The tweet also says he's Japanese. He's not. Patrick Soon-Shiong is South African-born Chinese, grew up under apartheid, and is a billionaire who owns the LA Times and is part of the Lakers. But that's a footnote to the actual science.)
All day Astronomy@forallcurious
🚨: Japanese scientist Patrick Soon-Shiong has designed a treatment that activates body's natural killer cells that fight against cancer cells. Its approved in the U.S. and now Saudi Arabia has also approved it for its public.
English

Bad rfa negotiations sour relationships
NHL Rumour Report@NHLRumourReport
Elliotte Friedman: Re Mason McTavish healthy scratch: Signed...a week before the season; just hasn't been right; nasty contract dispute; whenever this is over you sit down with Verbeek...what are you doing for next year; if it's 2 in a row, it's trouble - 32 Thoughts (3/16)
English







